Early experience with Watson for oncology in Korean patients with colorectal cancer

Autor: Sun Jin Sym, Eui Joo Kim, Kwang An Kwon, Jun-Won Chung, Yoon Jae Kim, Jeong-Heum Baek, Jae Hee Cho, Kyoung Oh Kim, Won-Suk Lee, Hyun Sun Woo, Dong Kyun Park
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Oncology
Male
Colorectal cancer
Adjuvant Chemotherapy
Cancer Treatment
Medical Oncology
User-Computer Interface
0302 clinical medicine
Medicine and Health Sciences
Stage (cooking)
Aged
80 and over
Multidisciplinary
Pharmaceutics
Middle Aged
Treatment Outcome
030220 oncology & carcinogenesis
Practice Guidelines as Topic
Medicine
Female
Colorectal Neoplasms
Algorithms
Research Article
Adult
Clinical Oncology
medicine.medical_specialty
Computer and Information Sciences
Concordance
Science
Expert Systems
Stage ii
Rectal Cancer
03 medical and health sciences
Cancer Chemotherapy
Drug Therapy
Diagnostic Medicine
Internal medicine
Republic of Korea
Gastrointestinal Tumors
medicine
Cancer Detection and Diagnosis
Humans
Chemotherapy
In patient
Aged
Neoplasm Staging
Retrospective Studies
Patient Care Team
Colorectal Cancer
Computing Systems
business.industry
Computers
Reproducibility of Results
Cancers and Neoplasms
Retrospective cohort study
Mean age
medicine.disease
Decision Support Systems
Clinical
Regimen
030104 developmental biology
Interdisciplinary Communication
Clinical Medicine
business
Software
Zdroj: PLoS ONE, Vol 14, Iss 3, p e0213640 (2019)
PLoS ONE
ISSN: 1932-6203
Popis: Background Watson for oncology (WFO) is a cognitive computing system providing decision support. We evaluated the concordance rates between the treatment options determined by WFO and those determined by a multidisciplinary team (MDT). Methods We reviewed the medical charts of patients diagnosed with colorectal cancer who visited the MDT at a single tertiary medical center from November 2016 to April 2017. WFO classified the treatment options for specific patients into three categories: ‘Recommended’, ‘For consideration’, and ‘Not recommended’. Concordance rates between the WFO- and MDT-determined chemotherapy options, and the factors that potentially influence the concordance rate, were analyzed. Results Sixty-nine patients with colorectal cancer met with the MDT from Nov. 2016 to Feb. 2017. The mean age of the patients was 62 years (range: 34–86 years), and more patients were male (47/69) than female. Of the 69 patients, 51 (73.9%) were diagnosed with colon cancer, of whom 46.4% received the same regimen recommendation from WFO (‘Recommended’) as they did from the MDT. After inclusion of the ‘For consideration’ category from WFO, the concordance rate increased to 87.0%. The concordance rate between MDT and NCCN guidelines was 97.1%, and that between the WFO and NCCN guidelines was 88.4%. The concordance rates between WFO and MDT were significantly lower in patients with stage II, IIIC, or IV disease (P
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje